Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis

Autophagy

Volumn 5, Issue 2, 2009, Pages 152-158

  Alirezaei, Mehrdad ^a   Fox, Howard S ^a   Flynn, Claudia T ^a   Moore, Craig S ^b   Hebb, Andrea L O ^b   Frausto, Ricardo F ^a,f   Bhan, Virender ^c   Kiosses, William B ^a   Whitton, J Lindsay ^a   Robertson, George S ^b,d   Crocker, Stephen J ^a,e  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apoptosis; Atg5; Autoimmune; Autophagy; CNS; EAE; Encephalomyelitis; Multiple sclerosis; Neuroinflammation; T cell

Indexed keywords

RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY RELATED GENE 5; CELL ISOLATION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; T LYMPHOCYTE;

MUS;

EID: 61649092566     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.5.2.7348     Document Type: Article

References (43)

1. Todaro M, Zeuner A, Stassi G. Role of apoptosis in autoimmunity. J Clin Immunol 2004; 24:1-11.
2. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annual review of neuroscience 2008; 31:247-69.
3. Hebb AL, Moore CS, Bhan V, Robertson GS. Targeting apoptosis to treat multiple sclerosis. Curr Drug Discov Technol 2008; 5:75-7.
4. Zehntner SP, Bourbonniere L, Moore CS, Morris SJ, Methot D, St Jean M, Lacasse E, Hebb AL, Robertson GS, Durkin J, Gillard JW, Owens T. X-linked inhibitor of apoptosis regulates T cell effector function. J Immunol 2007; 179:7553-60.
5. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, Fox HS. Disruption of Neuronal Autophagy by Infected Microglia Results in Neurodegeneration. PLoS ONE 2008; 3:2906.
6. Alirezaei M, Kiosses WB, Fox HS. Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 2008; 4:963-6.
7. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8:931-7.
8. Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol 2008; 3:427-55.
9. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21.
10. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nature reviews 2007; 7:767-77.
11. + T cells and important for the growth factor-withdrawal cell death. J Immunol 2006; 177:5163-8.
12. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007; 204:25-31.
13. Pua HH, He YW. Maintaining T lymphocyte homeostasis: another duty of autophagy. Autophagy 2007; 3:266-7.
14. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T, Simon HU. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006; 8:1124-32.
15. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003; 61:1528-32.
16. Vollmer T. The natural history of relapses in multiple sclerosis. J Neurol Sci 2007; 2561:5-13.
17. Lin VW, Cardenas DD. Spinal cord medicine: principles and practice. New York: Demos 2003.
18. Furlan R, Rovaris M, Martinelli Boneschi F, Khademi M, Bergami A, Gironi M, Deleidi M, Agosta F, Franciotta D, Scarpini E, Uccelli A, Zaffaroni M, Kurne A, Comi G, Olsson T, Filippi M, Martino G. Immunological patterns identifying disease course and evolution in multiple sclerosis patients. J Neuroimmunol 2005; 165:192-200.
19. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8:741-52.
20. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007; 6:304-12.
21. Sarkar S, Rubinsztein DC. Huntington's disease: degradation of mutant huntingtin by autophagy. The FEBS journal 2008.
22. Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, Codogno P, Biard-Piechaczyk M. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006; 116:2161-72.
23. Lu B, Capan E, Li C. Autophagy induction and autophagic cell death in effector T cells. Autophagy 2007; 3:158-9.
24. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6:463-77.
25. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001; 2:211-6.
26. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120:237-48.
27. Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M, Mackay IR, Gershwin ME. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 2007; 29:61-8.
28. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39:596-604.
29. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T, Munz C. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005; 307:593-6.
30. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-9.
31. Browning JL. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nature reviews 2006; 5:564-76.
32. Dalakas MC. Invited article: inhibition of B cell functions: implications for neurology. Neurology 2008; 70:2252-60.
33. Dalakas MC. B cells as therapeutic targets in autoimmune neurological disorders. Nature clinical practice 2008; 4:557-67.
34. Hasler P, Zouali M. B lymphocytes as therapeutic targets in systemic lupus erythematosus. Expert opinion on therapeutic targets 2006; 10:803-15.
35. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nature reviews 2001; 1:147-53.
36. Miller BC, Zhao Z, Stephenson LM, Cadwell K, Pua HH, Lee HK, Mizushima NN, Iwasaki A, He YW, Swat W, Virgin HWt. The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 2008; 4:309-14.
37. Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bisdifluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2- hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2006; 319:63-72.
38. Moore CS, Hebb AL, Robertson GS. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes. J Neuroimmunol 2008; 193:94-105.
39. Wheeler RD, Zehntner SP, Kelly LM, Bourbonniere L, Owens T. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Immunology 2006; 118:527-38.
40. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-7.
41. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58:840-6.
42. Hebb A, Moore C, Bhan V, Campbell T, Fisk J, Robertson H, Thorne M, Lacasse E, Holcik M, Gillard J, Crocker S, Robertson G. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult Scler 2008; 14:577-94.
43. Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y, Yoshimori T. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001; 152:657-68.